These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17404172)

  • 21. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The progression of cardiovascular risk to cardiovascular disease.
    Rosin BL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention and treatment of the metabolic syndrome in the elderly.
    Firdaus M
    J Okla State Med Assoc; 2005 Feb; 98(2):63-6. PubMed ID: 15789643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns.
    Haffner SM
    Am J Med; 2006 May; 119(5 Suppl 1):S3-9. PubMed ID: 16563945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The metabolic syndrome does not exist].
    Seidell JC
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):812. PubMed ID: 17469320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome pathophysiology and clinical presentation.
    Handelsman Y
    Toxicol Pathol; 2009 Jan; 37(1):18-20. PubMed ID: 19098117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].
    Baumgart P
    MMW Fortschr Med; 2006 Mar; 148(11):57, 59-60. PubMed ID: 16612965
    [No Abstract]   [Full Text] [Related]  

  • 29. Obesity; epiphenomenon or cause of metabolic syndrome?
    Lois K; Young J; Kumar S
    Int J Clin Pract; 2008 Jun; 62(6):932-8. PubMed ID: 18479286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and management of the metabolic syndrome in obesity.
    Liberopoulos EN; Mikhailidis DP; Elisaf MS
    Obes Rev; 2005 Nov; 6(4):283-96. PubMed ID: 16246214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk.
    Després JP
    Heart; 2009 Jul; 95(13):1118-24. PubMed ID: 19525261
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of perindopril in hypertensive patients with or without type 2 diabetes mellitus, and with altered insulin sensitivity.
    Marre M; Leye A
    Diab Vasc Dis Res; 2007 Sep; 4(3):163-73. PubMed ID: 17907106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metabolic syndrome as a coronary risk factor. Prevention and treatment].
    Kłosiewicz-Latoszek L; Cybulska B
    Kardiol Pol; 2003 Jul; 59(7):59-65. PubMed ID: 14560351
    [No Abstract]   [Full Text] [Related]  

  • 34. [Metabolically obese with normal weight individuals: an intriguing phenotype].
    Beck E; Scheen AJ
    Rev Med Liege; 2009 Jan; 64(1):16-24. PubMed ID: 19317097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic options for treatment of cardiometabolic risk].
    Stokić E; Tomić-Naglić D; Derić M; Jorga J
    Med Pregl; 2009; 62 Suppl 3():54-8. PubMed ID: 19702117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Secretory activity of the adipocytes and comorbidities of obesity].
    Skurk T; Hauner H
    MMW Fortschr Med; 2005 Jan; 147(4):41-3. PubMed ID: 15745341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

  • 38. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation.
    Dandona P; Aljada A; Chaudhuri A; Mohanty P; Garg R
    Circulation; 2005 Mar; 111(11):1448-54. PubMed ID: 15781756
    [No Abstract]   [Full Text] [Related]  

  • 39. Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful MARRIAGE?
    Rayner B
    Curr Med Res Opin; 2004 Mar; 20(3):359-67. PubMed ID: 15025845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.
    Abuissa H; Jones PG; Marso SP; O'Keefe JH
    J Am Coll Cardiol; 2005 Sep; 46(5):821-6. PubMed ID: 16139131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.